- Home
- /
- Treatment
- /
- Page 18
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Copanlisib | Extranodal marginal zone lymphoma | Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Boulevard, P. O. Box 915;Hanover, New Jersey, 07981 | February 7, 2017 | |
Brentuximab vedotin | Cutaneous T-cell lymphoma | Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021 | February 6, 2017 | |
Anti-HER2 bispecific antibody | Stomach Cancer | Zymeworks Inc.;18 West Mercer Street, Suite 370;Seattle, Washington, 98119 | February 6, 2017 | |
Allogeneic human islets of Langerhans | Brittle Type 1 Diabetes | University of Illinois;Hospital & Health Sciences System, Transplant, 840 South Wood Street;Chicago, Illinois, 60612 | February 1, 2017 | |
Laquinimod sodium | Huntington disease | Teva Branded Pharmaceutical Products R&D;;41 Moores Road, P. O. Box 4011;Frazer, Pennsylvania, 19355 | January 31, 2017 | |
Nitric oxide | Idiopathic pulmonary fibrosis | GeNo, LLC;2941 Oxbow Circle;Cocoa, Florida, 32926 | January 31, 2017 | |
6-[(3S,4S-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imadazo[1,5-a]pyrazin-8-one | Sickle cell anemia | Imara Inc.;700 Technology Square, 3rd Floor;Cambridge, Massachusetts, 02139 | January 31, 2017 | |
Adeno-associated virus (AAV) serotype rh.10 expressing beta-galactosidase | Gangliosidosis generalized GM1- type 1 | Lysogene, Inc.;245 First Street, 18th Floor;Cambridge, Massachusetts, 02142 | January 30, 2017 | |
(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride | Erythromelalgia | Biogen, Inc.;300 Binney Street;Cambridge, Massachusetts, 02142 | January 30, 2017 | |
Para-toluenesulfonamide | Adenoid cystic carcinoma | PTS International Inc.;2211 Newoak Park;San Antonio, Texas, 78230 | January 30, 2017 | |
Hydroxypioglitazone | X-linked adrenoleukodystrophy | Minoryx Therapeutics S.L.;TecnoCampus Mataro-Maresme. TCM3 602, Av. Ernest Lluch, 32.;Matar� | January 30, 2017 | |
Adeno-associated viral vector serotype 2.7m8 containing the chrimsonR-tdTomato gene | Retinitis pigmentosa | GenSight Biologics;74 Rue du Faubourg Saint-Antoine;Paris | January 25, 2017 | |
Melatonin | Necrotizing enterocolitis | Therapicon SrL;21 Via Malachia Marchesi de Taddei;Milano | January 25, 2017 | |
Dendritic cell/tumor cell fusion vaccine + recombinant human interleukin 12 | Glioma | CyTIX Inc.;7F Terada Bldg, 2-3-3 Shibakoen;Minato-ku | January 25, 2017 | |
Nitric oxide | Pulmonary Arterial Hypertension | GeNo, LLC;2941 Oxbow Circle;Cocoa, Florida, 32926 | January 25, 2017 | |
(R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidin-5-yl)phenyl)-N,N,N-trimethylethanaminium methanesulfonate dehydrate | Cystic fibrosis | Chiesi Farmaceutici S.p.A.;26A Via Palermo;Parma | January 25, 2017 | |
Nicotinamide riboside | Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes | Rejuvenation Therapeutics;774 Mays Boulevard, 10-509 PMB;Incline Village, Nevada, 89451 | January 25, 2017 | |
3-[4-(lH-imidazol-l-ylmethyl)phenyl]-5-(2-methylpropyl) thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt | Idiopathic pulmonary fibrosis | Vicore Pharma;c/o AstraZeneca, Pepparedsleden 1;M�lndal | January 25, 2017 | |
Human monoclonal antibody directed against human Activin A | Fibrodysplasia ossificans progressiva | Regeneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591 | January 19, 2017 | |
D-tagatose | Prader-Willi syndrome | Biospherics.net LLC;Department of Pharmaceutical Sciences, University of Kentucky;Nicholasville, Kentucky, 40356 | January 19, 2017 | |
Ublituximab in combination with phosphoinositide-3-kinase (PI3K) delta inhibitor | Diffuse Large B-cell Lymphoma | TG Therapeutics, Inc.;2 Gansevoort Street, 9th Floor;New York, New York, 10014 | January 19, 2017 | |
Humanized IgG4 monoclonal antibody binding to human C1q | Guillain-Barré syndrome | Annexon Biosciences;280 Utah Avenue, Suite 110;South San Francisco, California, 94080 | January 19, 2017 | |
Hyaluronic acid | Emphysema due to alpha1-antitrypsin deficiency | Gerard M. Turino, MD;Division of Pulmonary, Critical Care & Sleep Medicine, Mt. Sinai Roosevelt Hospital Center;New York, New York, 10019 | January 18, 2017 | |
D9-ivacaftor | Cystic fibrosis | Vertex Pharmaceuticals, Inc.;50 Northern Avenue;Boston, Massachusetts, 02210 | January 18, 2017 | |
2-Amino-4-[11C]methylsulfanyl-butanoic acid, l-[S methyl[11C]methionine | Medulloblastoma | Advanced Imaging Projects, LLC;7947 Brookside Ct.;Lake Worth, Florida, 33467 | January 17, 2017 |